Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 13;14(4):e70009.
doi: 10.1002/pul2.70009. eCollection 2024 Oct.

The metabolic and physiologic impairments underlying long COVID associated exercise intolerance

Affiliations

The metabolic and physiologic impairments underlying long COVID associated exercise intolerance

Brooks P Leitner et al. Pulm Circ. .

Abstract

Data from invasive CPET (iCPET) revealed long COVID patients have impaired systemic oxygen extraction (EO2), suggesting impaired mitochondrial ATP production. However, it remains uncertain whether the initial severity of SARS-CoV-2 infection has implications on EO2 and exercise capacity (VO2) nor has there been assessment of anerobic ATP generation in long COVID patients. iCPET was performed on 47 long COVID patients (i.e., full cohort; n = 8 with severe SARS-CoV-2 infection). In a subset of patients (i.e., metabolomic cohort; n = 26) metabolomics on venous and arterial blood samples during iCPET was performed. In the full cohort, long COVID patients exhibited reduced peak EO2 with reduced peak VO2 (90 ± 17% predicted) relative to cardiac output (118 ± 23% predicted). Peak VO2 [88% predicted (IQR 81% - 108%) vs. 70% predicted (IQR 64% - 89%); p = 0.02] and EO2 [0.59(IQR 0.53-0.62) vs. 0.53(IQR 0.50-0.48); p = 0.01) were lower in severe versus mild infection. In the metabolomic cohort, 12 metabolites were significantly consumed, and 41 metabolites were significantly released (p-values < 0.05). Quantitative metabolomics demonstrated significant increases in inosine and succinate arteriovenous gradients during exercise. Peak VO2 was significantly correlated with peak venous succinate (r = 0.68; p = 0.0008) and peak venous lactate (r = 0.49; p = 0.0004). Peak EO2 and consequently peak VO2 impact long COVID patients in a severity dependent manner. Exercise intolerance associated with long COVID is defined by impaired aerobic and anaerobic energy production. Peak venous succinate may serve as a potential biomarker in long COVID.

Keywords: PASC; invasive CPET; long COVID; metabolomic.

PubMed Disclaimer

Conflict of interest statement

BPL holds equity in EpiTET Therapeutics, Inc., which develops anti‐inflammatory treatments unrelated to thiswork. PMH has consulted for Cardiage LLC and Edwards Lifesciences, has received sponsored research funding from Edwards Lifesciences, and holds an equity interest in emka Medical. None of these relationships are related to the work presented.

Figures

Figure 1
Figure 1
Study design overview. Data set included the full cohort (n = 47) that examined the cardio‐pulmonary physiological perturbance observed in long COVID patients and a metabolomic cohort that examined metabolic profile (n = 26) of long COVID patients with unexplained exertional intolerance. VO2 – aerobic exercise capacity; RER – respiratory exchange ratio; HR – heart rate.
Figure 2
Figure 2
Fold change from resting oxygen extraction (EO2) as a function of increasing exercise intensity as measured by metabolic equivalents (METs). METs = VO2/Rest VO2. Mann Whitney U Tests were used for comparisons between groups. Data presented as median and interquartile range.
Figure 3
Figure 3
Global metabolomics reflects contribution of numerous metabolic pathways for peak exercise. Metabolites differentially expressed when measured as arteriovenous peak – arteriovenous rest, with hierarchical clustering by similarity (n = 26). Differential expression analysis was performed between rest and peak exercise for all patients, with benjamani‐hochberg corrections for multiple comparisons. Padj = adjusted p‐value.

References

    1. Organization WH. COVID‐19 epidemiological update . 2024;Accessed No. 168.). http://www.who.int/publications/m/item/covid-19-epidemiological-update-e...
    1. Fang Z, Ahrnsbrak R, Rekito A. Evidence mounts that about 7% of US adults have had long COVID. JAMA. 2024;332:5–6. 10.1001/jama.2024.11370 - DOI - PubMed
    1. Joseph P, Singh I, Oliveira R, Capone CA, Mullen MP, Cook DB, Stovall MC, Squires J, Madsen K, Waxman AB, Systrom DM. Exercise pathophysiology in myalgic encephalomyelitis/chronic fatigue syndrome and postacute sequelae of SARS‐CoV‐2. Chest. 2023;164:717–726. 10.1016/j.chest.2023.03.049 - DOI - PMC - PubMed
    1. Durstenfeld MS, Sun K, Tahir P, Peluso MJ, Deeks SG, Aras MA, Grandis DJ, Long CS, Beatty A, Hsue PY. Use of cardiopulmonary exercise testing to evaluate long COVID‐19 symptoms in adults: A systematic review and meta‐analysis. JAMA Network Open. 2022;5:e2236057. 10.1001/jamanetworkopen.2022.36057 - DOI - PMC - PubMed
    1. Kahn PA, Joseph P, Heerdt PM, Singh I. Differential cardiopulmonary haemodynamic phenotypes in PASC‐related exercise intolerance. ERJ Open Res. 2024;10:00714. 10.1183/23120541.00714-2023 - DOI - PMC - PubMed

LinkOut - more resources